TheEdgeResearch
Home / Stocks / BSCU

Invesco BulletShares 2030 Corporate Bond ETF (BSCU)

NASDAQ Financial Services Asset Management - Bonds
$16.56 ▲ +0.09%
Market Cap
$2.63B
Sector
Financial Services
Industry
Asset Management - Bonds
Beta
0.94
52-Wk Range
16.45-17.06
CEO
Country
US
Currency
USD

Invesco BulletShares 2030 Corporate Bond ETF operates in the Asset Management - Bonds industry of the Financial Services sector, headquartered in Downers Grove, IL, US. The stock last traded at $16.56, up 0.09% on the session, giving a market capitalisation of $2.63B. Its beta of 0.94 implies it has historically moved less than the broad market.

Company profile
Exchange
NASDAQ Global Market
Employees
IPO date
2020-09-16
Headquarters
Downers Grove, IL, US
About Invesco BulletShares 2030 Corporate Bond ETF

The Invesco BulletShares 2030 Corporate Bond ETF (BSCU) aims to replicate the performance of the Invesco BulletShares Corporate Bond 2030 Index. This ETF is mandated to invest at least 80% of its total assets in corporate bonds found within this index. The benchmark index focuses on measuring the returns of U.S. dollar-denominated, investment-grade corporate bonds that are scheduled to mature in 2030. Rather than acquiring every security in the index, the Fund employs a "sampling" approach to pursue its investment objective. Both the Fund and its corresponding index undergo rebalancing on a monthly basis. BSCU has a predetermined maturity year of 2030, with its operations expected to cease around December 15, 2030. For comprehensive details, please refer to the prospectus. It should also be noted that, effective January 1, 2024, the underlying index's name was changed from the Nasdaq BulletShares USD Corporate Bond 2030 Index to its current title.

Comparable companies

Invesco BulletShares 2030 Corporate Bond ETF is most often compared with the following Financial Services names:

AVSCBKAGBSCTFALNGTOIYGQLTASMTHXHBXHLF
More research on BSCU
BSCU technical analysis BSCU TheEdge Score Compare against peers
Open full interactive analysis & DCF →